San Francisco Biotech Networks

SFBN Feed: Former Gilead legal star departs Cytokinetics as crucial FDA ruling approaches https://lnkd.in/gxUkiTtv The Food and Drug Administration is expected to decide in late September whether to approve Cytokinetics’ first drug, the heart failure medicine aficamten. Click here to view original post Click Here to Publish/Feature Your Company [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Geron Plans to Announce First Quarter 2025 Financial Results on May 7, 2025 https://lnkd.in/gxFRfEBg FOSTER CITY, Calif.–(BUSINESS WIRE)–Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company, today announced that it will release its first quarter financial results and business highlights before the market opens on Wednesday, May 7, 2025 via [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Mira Launches the Hormone Innovators Awards 2025 to Champion Innovation and Progress in Women’s Hormonal Health https://lnkd.in/gq7nADbH SAN FRANCISCO, March 31, 2025 /PRNewswire/ — Mira, a leading hormonal health company, announces the launch of the first Hormone Innovators Awards 2025. As part of Mira’s annual Sex Hormones Awareness Week, this initiative recognizes [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Power 100: Sacramento region’s most powerful health care executives https://lnkd.in/gX6s-JKt Power 100 is a yearly review of the most powerful people in the Sacramento region’s business community. This section covers top leaders in health care. Click here to view original post Click Here to Publish/Feature [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Former American Cancer Society CEO Karen Knudsen takes new job in San Francisco https://lnkd.in/g-GziDKr Karen Knudsen, the former director of Jefferson’s Kimmel Cancer Center, on Monday was appointed CEO of the Parker Institute for Cancer Immunotherapy. Click here to view original post Click Here to Publish/Feature Your Company or [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Sanofi snags GSK’s Chris Corsico to serve as global head of development https://lnkd.in/guTRdEYb Christopher Corsico, M.D., has left GSK to become Sanofi’s global head of development, effective immediately. The announcement was shared with Sanofi team members March 31, according to an internal company communication obtained by Fierce Biotech.?? [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: BioCardia’s Conference Call Today, Monday, March 31, 2025 to be Held at 4:30PM EDT Time Today https://lnkd.in/gS8gSXTF SUNNYVALE, Calif., March 31, 2025 (GLOBE NEWSWIRE) — BioCardia, Inc.?[Nasdaq: BCDA],?a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today clarifies that two-year CardiAMP-HF results will be addressed [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: East Bay company aims to tame a shrew to make better GLP-1 weight-loss drugs https://lnkd.in/g__GaTbh If an eventual drug from this company prevents the mammal’s natural reaction, it could be one of several drugs lining up for patients. Click here to view original post Click Here to Publish/Feature Your Company [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Veltris Acquires BPK Technologies to Expand Digital and AI Capabilities in Healthcare Industries https://lnkd.in/gyAxwpxS Veltris is backed by Trive Capital and BayLink Capital MINNETONKA, Minn. and SAN FRANCISCO, March 31, 2025 /PRNewswire/ — Veltris, a digital product engineering services provider backed by Trive Capital (“Trive”) and BayLink Capital (“BayLink”), [...] #BayArea #SanFrancisco #Biotech #Lifescience #News

SFBN Feed: Apollomics hands Asia rights to its lead c-MET inhibitor to Taiwan’s LaunXP in $60M deal https://lnkd.in/gmBhtTrd Apollomics has sold the rights to its lead c-MET inhibitor in Asia, excluding Greater China, to Taiwan’s LaunXP Biomedical for $10 million upfront. The drug, called vebreltinib, has already been evaluated in a phase 2 [...] #BayArea #SanFrancisco #Biotech #Lifescience #News